Quick verdict
Mochi Health is the better pick for most patients on overall scoring. Flat all-in pricing, transparent compounded sourcing, and no lock-in. Best fit for cash-pay patients who want predictable monthly billing.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Mochi Health | Embla | |
|---|---|---|
| Starts from | $178/mo (incl. medication) | $249/mo (+ med separate) |
| Lock-in | Month-to-month | 12-month commitment |
| Time to prescription | 3 days | 7 days |
| Consultation type | Synchronous | Synchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Mochi Health | Embla | |
|---|---|---|
| Pricing transparency | 9/10 | 6/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 6/10 | 7/10 |
| Member outcomes | 6/10 | 8/10 |
When to choose Mochi Health
Cash-pay patients who want all-in monthly pricing and a compounded GLP-1 path.
When to choose Embla
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
FAQ
Is Mochi Health cheaper than Embla?
Can I switch from Mochi Health to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →